287201-52-9

Basic information

• Product Name: Acetic acid, [[4-(2-butynyloxy)phenyl]thio]-, ethyl ester
• CAS NO: 287201-52-9
• Molecular Formula: C14H16O3S
• Molecular Weight: 264.345
• Mol File: 287201-52-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Acetic acid, [[4-(2-butynyloxy)phenyl]thio]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, [[4-(2-butynyloxy)phenyl]thio]-, ethyl ester(287201-52-9)
• EPA Substance Registry System: Acetic acid, [[4-(2-butynyloxy)phenyl]thio]-, ethyl ester(287201-52-9)

Safety Data

• Hazardous Substances Data: 287201-52-9(Hazardous Substances Data)

Upstream product

• 30519-00-7 (4-Hydroxy-phenylsulfanyl)-acetic acid ethyl ester 
• 3355-28-0 1-Bromo-2-butyne 

Downstream Products

• 287202-22-6 (4-but-2-ynyloxybenzenesulfonyl)acetic acid ethyl ester 
• 287201-60-9 1-benzyl-4-(4-but-2-ynyloxybenzenesulfonyl)piperidine-4-carboxylic acid 
• 287201-59-6 1-benzyl-4-(4-but-2-ynyloxybenzenesulfonyl)piperidine-4-carboxylic acid ethyl ester 
• 287201-56-3 4-(4-but-2-ynyloxybenzenesulfonyl)-1-(4-methoxybenzyl)piperidine-4-carboxylic acid 
• 287201-58-5 4-(4-but-2-ynyloxybenzenesulfonyl)-1-(4-chlorobenzyl)piperidine-4-carboxylic acid 
• 287201-53-0 1-(4-bromobenzyl)-4-(4-but-2-ynyloxybenzenesulfonyl)piperidine-4-carboxylic acid 
• 287201-57-4 4-(4-but-2-ynyloxybenzenesulfonyl)-1-(4-chlorobenzyl)piperidine-4-carboxylic acid ethyl ester 
• 287201-54-1 1-(4-bromobenzyl)-4-(4-but-2-ynyloxybenzenesulfonyl)piperidine-4-carboxylic acid ethyl ester 
• 287201-55-2 4-(4-but-2-ynyloxybenzenesulfonyl)-1-(4-methoxybenzyl)piperidine-4-carboxylic acid ethyl ester 

Relevant articles and documents

Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-α converting enzyme and matrix metalloproteinase inhibitors

A series of 4-alkynyloxy phenyl sulfanyl, sulfinyl and sulfony alkyl and piperidine-4-carboxylic acid hydroxamides were synthesized. Their structure-activity relationships, against tumor necrosis factor-α (TACE) and matrix metalloproteinase (MMP) inhibito